84 related articles for article (PubMed ID: 11391857)
1. Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives.
Minari Y; Nio Y; Hirahara N; Dong M
Cancer Chemother Pharmacol; 2001 May; 47(5):415-22. PubMed ID: 11391857
[TBL] [Abstract][Full Text] [Related]
2. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical staining of thymidine phosphorylase in primary colorectal carcinoma and metastases].
Tokunaga N; Sadahiro S; Yasuda S; Mukai M; Ishida H; Kimura T; Suzuki T; Ishikawa K; Iwase H; Kameya T; Tajima T; Makuuchi H
Gan To Kagaku Ryoho; 1998 Feb; 25(3):353-7. PubMed ID: 9492828
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas.
Nio Y; Iguchi C; Yamasawa K; Sasaki S; Takamura M; Toga T; Dong M; Itakura M; Tamura K
Pancreas; 2001 Apr; 22(3):230-9. PubMed ID: 11291923
[TBL] [Abstract][Full Text] [Related]
5. Expression of orotate phosphoribosyl transferase in human pancreatic cancer: implication for the efficacy of uracil and tegafur-based adjuvant chemotherapy.
Nio Y; Toga T; Maruyama R; Fukushima M
Oncol Rep; 2007 Jul; 18(1):59-64. PubMed ID: 17549346
[TBL] [Abstract][Full Text] [Related]
6. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
7. Comparative significance of p53 and WAF/1-p21 expression on the efficacy of adjuvant chemotherapy for resectable invasive ductal carcinoma of the pancreas.
Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
Pancreas; 1999 Mar; 18(2):117-26. PubMed ID: 10090408
[TBL] [Abstract][Full Text] [Related]
8. Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
Saif MW; Hashmi S; Bell D; Diasio RB
Expert Opin Drug Saf; 2009 Sep; 8(5):507-14. PubMed ID: 19663627
[TBL] [Abstract][Full Text] [Related]
9. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical study of thymidine phosphorylase in uterine cervical intraepithelial neoplasia].
Kaneoka A; Obata T; Takasu K
Rinsho Byori; 1997 May; 45(5):483-6. PubMed ID: 9170977
[TBL] [Abstract][Full Text] [Related]
12. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
Ikeguchi M; Makino M; Kaibara N
Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of thymidine phosphorylase expression for pancreatic cancer.
Hong SP; Shin SK; Bang S; Park SW; Chung JB; Lee WJ; Song SY
Hepatogastroenterology; 2009; 56(93):1178-82. PubMed ID: 19760965
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer.
Nakayama S; Takeda S; Kawase Y; Inoue S; Kaneko T; Nakao A
Ann Surg; 2004 Nov; 240(5):840-4. PubMed ID: 15492566
[TBL] [Abstract][Full Text] [Related]
16. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.
Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
Anticancer Res; 1998; 18(5B):3773-9. PubMed ID: 9854494
[TBL] [Abstract][Full Text] [Related]
17. Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: effects on clinical outcome and efficacy of adjuvant chemotherapy.
Nio Y; Dong M; Iguchi C; Yamasawa K; Toga T; Itakura M; Tamura K
J Surg Oncol; 2001 Mar; 76(3):188-96. PubMed ID: 11276023
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreas.
Nio Y; Omori H; Toga T; Hashimoto K; Itakura M; Koike M; Yano S; Higami T
Anticancer Drugs; 2003 Apr; 14(4):313-9. PubMed ID: 12679736
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker?
Formentini A; Sander S; Denzer S; Straeter J; Henne-Bruns D; Kornmann M
Int J Colorectal Dis; 2007 Jan; 22(1):49-55. PubMed ID: 16538493
[TBL] [Abstract][Full Text] [Related]
20. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]